Your browser doesn't support javascript.
After 62 years of regulating immunity, dexamethasone meets COVID-19.
Cain, Derek W; Cidlowski, John A.
  • Cain DW; Department of Medicine, Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Cidlowski JA; The Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC, USA. cidlows1@niehs.nih.gov.
Nat Rev Immunol ; 20(10): 587-588, 2020 10.
Article in English | MEDLINE | ID: covidwho-708554
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Dexamethasone / Coronavirus Infections / Betacoronavirus / Cytokine Release Syndrome / Immunosuppressive Agents / Anti-Inflammatory Agents Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: S41577-020-00421-x

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Dexamethasone / Coronavirus Infections / Betacoronavirus / Cytokine Release Syndrome / Immunosuppressive Agents / Anti-Inflammatory Agents Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: S41577-020-00421-x